1. Home
  2. LYFT vs RGEN Comparison

LYFT vs RGEN Comparison

Compare LYFT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyft Inc.

LYFT

Lyft Inc.

N/A

Current Price

$17.51

Market Cap

5.8B

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$181.91

Market Cap

6.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LYFT
RGEN
Founded
2007
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.6B
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
LYFT
RGEN
Price
$17.51
$181.91
Analyst Decision
Buy
Buy
Analyst Count
29
12
Target Price
$20.07
$167.67
AVG Volume (30 Days)
12.0M
1.2M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
11250.00
286.96
EPS
0.16
0.24
Revenue
$6,316,261,000.00
$141,236,000.00
Revenue This Year
$17.33
$14.30
Revenue Next Year
$12.29
$14.52
P/E Ratio
$108.75
$751.21
Revenue Growth
9.16
35.10
52 Week Low
$12.46
$100.99
52 Week High
$25.54
$188.73

Technical Indicators

Market Signals
Indicator
LYFT
RGEN
Relative Strength Index (RSI) 60.26 76.48
Support Level $12.93 $156.65
Resistance Level $17.76 N/A
Average True Range (ATR) 0.69 6.79
MACD 0.02 1.81
Stochastic Oscillator 78.45 84.69

Price Performance

Historical Comparison
LYFT
RGEN

About LYFT Lyft Inc.

Lyft is the second-largest ride-sharing service provider in the US and Canada, connecting riders and drivers over the Lyft app. Incorporated in 2013 and public since 2019, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft has entered the bike- and scooter-share market to bring multimodal transportation options to users.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: